ClinicalTrials.gg
CompletedNCT06258343Updated Jul 10, 2025

Extremity Thermographic Values in Individuals With Transtibial Amputation

An observational study in Amputees, Amputation and Amputation Stump, sponsored by Baskent University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-07-10.

Sponsored by Baskent University · Observational

Study type
Observational
Model
Case-crossover
Time perspective
Cross-sectional
Enrollment
21
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The goal of this observational study is to compare thermographic values in the knee region of the healthy extremity and the amputated extremity and learn about the relationship between thermographic value and pain in the knee region of the amputated extremity. The main questions it aims to answer are:

  1. Do thermal values in the knee region of the amputated extremity and the intact extremity differ in individuals with transtibial amputation?
  2. Is there a relationship between the pain felt in the knee region of the amputated limb and the difference in thermal values between the extremities in individuals with transtibial amputation?
Read the detailed description

With amputation, anatomical and vascular changes occur in the distal part of the remaining limb. At this point, for individuals with amputation at the transtibial level, the knee joint in the amputated extremity is of critical importance as it is the most distal joint. While there is evidence that thermal changes observed in the knee region may be related to possible degeneration or pathological processes, there is not enough research on the amputee population. Considering that individuals who have undergone lower extremity amputation are at greater risk than the general population for many health problems and considering the current evidence, we think that the evaluation of skin temperature, which is an indicator of cutaneous circulation, may be an important indicator in taking precautions for degenerative knee diseases. With the planned study, lower extremity temperature profiles and their relationship with knee pain will be evaluated for the first time during the post-amputation period. Thermal infrared non-contact thermometer, which is non-invasive, cheap and easy to apply, will be used for the first time in lower extremity temperature measurements of amputees.

Objectives of the study,

  • Thermal analysis results of both extremities will be compared and it will be investigated whether there is a difference between thermal values, which is one of the indicators of cutaneous blood flow;
  • By comparing the thermal values, it will be determined whether the thermal values differ in the amputee limb that has undergone major trauma and is exposed to prosthetic material that applies continuous compression,
  • The relationship between nociceptive pain and phantom pain felt in the knee region of the amputated limb and the thermal value difference between the extremities will be determined.
02

Conditions studied

  • Amputees
  • Amputation
  • Amputation Stump
  • Amputation of Knee
  • Vascularisation
03

In context

Neovascularization, Pathologic

81 studies on the registry are indexed under Neovascularization, Pathologic; 7 are open to participants now.

This study's enrollment of 21 is below the median of 50 across 23 observational studies indexed under Neovascularization, Pathologic.

Browse Neovascularization, Pathologic studies →

Lead sponsor

Baskent University is the lead sponsor of 209 studies on the registry; 35 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Individuals with unilateral transitibial amputation

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Having a unilateral below knee level amputation,
  • Using a prosthesis and being able to walk with the prosthesis,
  • Not having undergone any surgery related to the knees.

Exclusion criteria

Exclusion Criteria:

  • Having bilateral amputation,
  • Not being able to walk 10 minutes independently,
  • Failure to consent to measurement of knee thermal temperature.
05

Study design

Observational model
Case-crossover
Time perspective
Cross-sectional
Enrollment
21 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Skin Temperature

    In both knees, 3 measurements will be taken at the center of the patella, the tibialis anterior muscle trunk (10 cm distal to the tibial tubercle and 2 cm lateral to the anterior border of the tibia) and distal to the limb. Room temperature will be recorded simultaneously. Measurements will be recorded in Celsius. The study will follow the recently published 15-point TISEM consensus statement on the measurement of human Tsk. Within the scope of the study, temperature measurements will be performed using a Medisana 48620 Infrared Non-Contact Thermometer (MEDISANA, FTN, Hilden, Germany).

    Time frame: 30 minutes

Secondary outcomes

  1. Knee Pain

    The presence of pain in both knees, pain intensity and localization of pain will be questioned. To determine the presence of pain sensation in the knee region of the patients, the presence or absence of pain sensation in the knee of the intact and amputated extremity will be questioned. In the presence of pain sensation, the 'Visual Analog Scale' will be used to assess the severity of pain in the intact knee and the amputated knee. For pain intensity assessment with the Visual Analog Scale, a 10 cm long line is drawn. The starting and ending points of the line are numbered 0 and 10. Individuals are asked to mark the intensity of the pain they feel on the scale, indicating that a value of 0 indicates absence of pain and a value of 10 indicates unbearable severe pain. The area marked by the individuals is then measured with a ruler and recorded as pain intensity.

    Time frame: 10 minutes

  2. Phantom Sensation and Phantom Pain

    The presence of phantom limb sensation will be questioned. If there is phantom limb sensation, individuals will be asked to describe their phantom limb sensation with open-ended questions and to provide information about the position of their limbs (fixed or mobile, in anatomical position or in anatomically impossible position), and whether they feel shortening/shrinking or any other condition in their limbs and the presence of telescope phenomenon will be questioned. The presence or absence of phantom pain will be questioned. If phantom pain is experienced, individuals will be asked to provide information about the area of pain, the frequency/type of pain and to complete the "Short Form Mc-Gill Pain Scale (SF-MPQ)". The main component of the SF-MPQ consists of 15 descriptors (11 sensory; 4 affective) which are rated on an intensity scale as 0 = none, 1 = mild, 2 = moderate or 3 = severe.

    Time frame: 20 minutes

07

Study locations

1 site
  • Senay Cerezci Duygu
    Ankara, Keçiören, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06258343
Lead sponsor
Baskent University
Collaborators
Gulhane School of Medicine, Ankara Yildirim Beyazıt University
Responsible party
Senay Cerezci Duygu (Asst. Prof., Baskent University) — Principal investigator
First posted
Feb 14, 2024
Start date
Sep 1, 2024
Primary completion
Jan 1, 2025
Completion
Mar 1, 2025
Last update
Jul 10, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion